Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
13.25
+0.10 (0.76%)
At close: Oct 6, 2026, 4:00 PM EDT
13.10
-0.15 (-1.13%)
After-hours: Oct 6, 2026, 7:30 PM EDT
Replimune Group Employees
Replimune Group had 465 employees as of March 31, 2026. The number of employees decreased by 14 or -2.92% compared to the previous year.
Employees
465
Change (1Y)
-14
Growth (1Y)
-2.92%
Revenue / Employee
n/a
Profits / Employee
-$638,738
Market Cap
1.25B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 465 | -14 | -2.92% |
| Mar 31, 2025 | 479 | 148 | 44.71% |
| Mar 31, 2024 | 331 | 47 | 16.55% |
| Mar 31, 2023 | 284 | 78 | 37.86% |
| Mar 31, 2022 | 206 | 54 | 35.53% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| Omeros | 175 |
| ORIC Pharmaceuticals | 111 |
| Bicara Therapeutics | 103 |
| Nanobiotix | 100 |
| Savara | 70 |
| Avalyn Pharma | 55 |
| Damora Therapeutics | 7 |
REPL News
- 5 days ago - Replimune announces Tudriqev now available in U.S. for advanced melanoma - TheFly
- 5 days ago - Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma - GlobeNewsWire
- 8 days ago - Robbins LLP is Investigating Allegations that Replimune Group, Inc. Misled Investors Regarding the Efficacy and Viability of its Lead Product Candidate RP1 - Newsfile Corp
- 18 days ago - REPL Stockholders with Significant Losses Should Contact Robbins LLP Before the Pending October 5, 2026 Lead Plaintiff Deadline for Information About Recovering Their Losses - PRNewsWire
- 21 days ago - Replimune Group Transcript: AGM 2026 - Transcripts
- 26 days ago - Replimune Group Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 4 weeks ago - Replimune to Present at the Cantor Global Healthcare Conference 2026 - GlobeNewsWire
- 5 weeks ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Replimune Group, Inc. Lawsuit - REPL - GlobeNewsWire